Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$205K Sell
20,761
-941
-4% -$9.25K ﹤0.01% 5155
2014
Q2
$194K Buy
21,702
+10,502
+94% +$96.6K ﹤0.01% 5173
2014
Q1
$112K Sell
11,200
-400
-3% -$4.1K ﹤0.01% 5842
2013
Q4
$129K Sell
11,600
-2,425
-17% -$22.8K ﹤0.01% 5774
2013
Q3
$98K Buy
14,025
+3,025
+28% +$20.5K ﹤0.01% 6042
2013
Q2
$69K Buy
+11,000
New +$67.1K ﹤0.01% 6341

Other funds holding AORT

UBS's AORT Position: Q3 2014 in Review

UBS reduced its Artivion (AORT) stake by 4.3% in Q3 2014, selling an estimated $9.25K and leaving 20,761 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #5155.

UBS first reported a position in AORT in Q2 2013 and has held it in 6 quarters since. 113 funds tracked by Wall St. Rank hold AORT as of Q3 2014.

  • UBS held 20,761 shares of Artivion worth $205K as of Q3 2014.
  • UBS sold 941 Artivion shares in Q3 2014, an estimated $9.25K.
  • Artivion made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5155 holding.
  • UBS first reported a position in Artivion in Q2 2013 and has held it in 6 quarters since.
  • 113 funds tracked by Wall St. Rank held Artivion as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.